Pharma Journalist - Page 108 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

FDA Grants Breakthrough Therapy Designation to Innate Pharma’s Lacutamab for Sézary Syndrome

FDA Grants Full Approval of Deciphera’s ROMVIMZA for TGCT Treatment

FDA Approves GSK’s Penmenvy 5-in-1 Meningococcal Vaccine for MenABCWY Protection

QIAGEN Expands Bioinformatics Leadership with New Data Center in Australia/APAC

Newleos Therapeutics Raises $93.5M in Oversubscribed Series A to Advance Neuropsychiatric Disorder Treatments

Nemluvio Approved in EU for Atopic Dermatitis and Prurigo Nodularis

MaxCyte Signs Platform License with TG Therapeutics for Autoimmune Cell Therapies

Health Canada Approves Merck’s KEYTRUDA for Resectable NSCLC with Chemotherapy

Lundbeck’s Amlenetug for MSA Receives FDA Fast Track Designation

AbbVie and Xilio Therapeutics Partner to Develop Tumor-Activated Immunotherapies